Vienna, Austria

András Aszódi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: András Aszódi. Retrieved from https://idiyas.com/inventor/andrás-aszódi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: András Aszódi: Therapeutic Antibody Innovation

Introduction

András Aszódi is an inventor associated with Novartis AG in Vienna, Austria. His patent work includes a therapeutic binding molecule designed for potential pharmaceutical use.

Latest Patents

The supplied information identifies one patent for Aszódi: “Therapeutic binding molecules.” It describes a molecule with an antigen-binding site containing specified CDR1, CDR2, and CDR3 amino acid sequences. The disclosure also describes an example with a second set of hypervariable regions and notes that the molecule may be a chimeric or humanized antibody. The invention is presented as useful as a pharmaceutical. The supplied data does not establish the patent’s filing date or whether it is the latest patent.

Career Highlights

Aszódi’s listed patent reflects work on antibody-based therapeutic molecules and their antigen-binding regions. The supplied information associates him with Novartis AG and records 1 patent.

Collaborations

The listed coworkers are Gregorio Aversa and Bruce Milne Hall. The supplied information does not specify the nature of their collaboration with Aszódi.

Conclusion

András Aszódi’s recorded patent contribution concerns therapeutic binding molecules, including antibody designs with defined antigen-binding regions and potential pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…